Cargando…
An intravitreal implant injection method for sustained drug delivery into mouse eyes
Using small molecule drugs to treat eye diseases carries benefits of specificity, scalability, and transportability, but their efficacy is significantly limited by a fast intraocular clearance rate. Ocular drug implants (ODIs) present a compelling means for the slow and sustained release of small mo...
Autores principales: | Sun, Young Joo, Lin, Cheng-Hui, Wu, Man-Ru, Lee, Soo Hyeon, Yang, Jing, Kunchur, Caitlin R., Mujica, Elena M., Chiang, Bryce, Jung, Youn Soo, Wang, Sui, Mahajan, Vinit B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813043/ https://www.ncbi.nlm.nih.gov/pubmed/35128514 http://dx.doi.org/10.1016/j.crmeth.2021.100125 |
Ejemplares similares
-
A protocol to inject ocular drug implants into mouse eyes
por: Lin, Cheng-Hui, et al.
Publicado: (2022) -
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas, Benjamin J, et al.
Publicado: (2016) -
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
por: Park, Jong G., et al.
Publicado: (2020) -
Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy
por: Akulo, Kassahun Alula, et al.
Publicado: (2022) -
Retinal injury following intravitreal injection of a dexamethasone implant in a non-vitrectimised eye
por: Jain, M Arvind, et al.
Publicado: (2020)